These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21199806)

  • 21. Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage.
    De Moura J; Kavalec FL; Doghman M; Rosati R; Custodio G; Lalli E; Cavallari GM; Santa Maria J; Figueiredo BC
    Int J Oncol; 2010 Apr; 36(4):983-90. PubMed ID: 20198344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
    Macedo GS; Araujo Vieira I; Brandalize AP; Giacomazzi J; Inez Palmero E; Volc S; Rodrigues Paixão-Côrtes V; Caleffi M; Silva Alves M; Achatz MI; Hainaut P; Ashton-Prolla P
    Cancer Genet; 2016 Mar; 209(3):97-106. PubMed ID: 26823150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome.
    Shay JW; Tomlinson G; Piatyszek MA; Gollahon LS
    Mol Cell Biol; 1995 Jan; 15(1):425-32. PubMed ID: 7799951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S; Tong YA; Devadas K; Zou ZQ; Sykes VW; Chen Y; Blattner WA; Pirollo K; Chang EH
    Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of DICER in monocytes and its regulation by HIV-1.
    Coley W; Van Duyne R; Carpio L; Guendel I; Kehn-Hall K; Chevalier S; Narayanan A; Luu T; Lee N; Klase Z; Kashanchi F
    J Biol Chem; 2010 Oct; 285(42):31930-43. PubMed ID: 20584909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes.
    Paules RS; Levedakou EN; Wilson SJ; Innes CL; Rhodes N; Tlsty TD; Galloway DA; Donehower LA; Tainsky MA; Kaufmann WK
    Cancer Res; 1995 Apr; 55(8):1763-73. PubMed ID: 7712486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G2 chromosomal radiosensitivity in fibroblasts of ataxia-telangiectasia heterozygotes and a Li-Fraumeni syndrome patient with radioresistant cells.
    Mitchell EL; Scott D
    Int J Radiat Biol; 1997 Oct; 72(4):435-8. PubMed ID: 9343108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells.
    Mudhasani R; Zhu Z; Hutvagner G; Eischen CM; Lyle S; Hall LL; Lawrence JB; Imbalzano AN; Jones SN
    J Cell Biol; 2008 Jun; 181(7):1055-63. PubMed ID: 18591425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε.
    Liang D; Gao Y; Lin X; He Z; Zhao Q; Deng Q; Lan K
    Cell Res; 2011 May; 21(5):793-806. PubMed ID: 21221132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a.
    Verrier JD; Lau P; Hudson L; Murashov AK; Renne R; Notterpek L
    Glia; 2009 Sep; 57(12):1265-79. PubMed ID: 19170179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional variant in miR-605 modifies the age of onset in Li-Fraumeni syndrome.
    Id Said B; Malkin D
    Cancer Genet; 2015; 208(1-2):47-51. PubMed ID: 25683625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Faulty DNA polymerase delta/epsilon-mediated excision repair in response to gamma radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome.
    Mirzayans R; Enns L; Dietrich K; Barley RD; Paterson MC
    Carcinogenesis; 1996 Apr; 17(4):691-8. PubMed ID: 8625479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring MicroRNA Expression Profiles Related to the mTOR Signaling Pathway in Mouse Embryonic Fibroblast Cells Treated with Polyethylenimine.
    Lin CW; Jan MS; Kuo JH
    Mol Pharm; 2015 Aug; 12(8):2858-68. PubMed ID: 26158199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome.
    Bischoff FZ; Strong LC; Yim SO; Pratt DR; Siciliano MJ; Giovanella BC; Tainsky MA
    Oncogene; 1991 Feb; 6(2):183-6. PubMed ID: 2000218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain.
    Gu J; Kawai H; Wiederschain D; Yuan ZM
    Cancer Res; 2001 Feb; 61(4):1741-6. PubMed ID: 11245491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
    Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase protects cancer-prone human cells from chromosomal instability and spontaneous immortalization.
    Elmore LW; Turner KC; Gollahon LS; Landon MR; Jackson-Cook CK; Holt SE
    Cancer Biol Ther; 2002; 1(4):391-7. PubMed ID: 12432253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarray Analysis of Differentially-expressed MicroRNAs in Acquired Middle Ear Cholesteatoma.
    Xie S; Liu X; Pan Z; Chen X; Peng A; Yin T; Ren J; Liu W
    Int J Med Sci; 2018; 15(13):1547-1554. PubMed ID: 30443177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.